Emerging research is shedding new light on the biological drivers of tinnitus, suggesting that serotonin, a neurotransmitter widely targeted in mental health treatments, may also influence the condition.

Scientists from Oregon Health and Science University and Anhui University have identified a specific brain circuit in animal models where increased serotonin activity directly affects auditory processing. Elevated levels of the neurotransmitter were associated with stronger tinnitus like responses, indicating that serotonin may amplify the perception of phantom sounds.

The findings help explain why some patients report worsening tinnitus when taking antidepressants that raise serotonin levels. While these therapies remain essential for managing depression and anxiety, the research highlights a complex interaction between mood regulation and sensory perception.

Researchers emphasise that the results are based on preclinical models and should not prompt changes to prescribed treatments without medical guidance. Instead, the work opens the door to more targeted therapies that could preserve serotonin’s mental health benefits while limiting its impact on auditory pathways.

With tinnitus affecting a significant portion of the global population, the study offers a promising step toward more personalised approaches that address both neurological and psychological dimensions of the condition.